All News

Treatment with Opdivo plus standard of care chemotherapy followed by maintenance Opdivo or Opdivo plus Yervoy failed to elicit survival benefits compared with standard of care chemotherapy alone in patients with previously untreated advanced biliary cancer, which is a rare form of liver cancer.

Although some advancements to boost minority and female enrollment onto cancer clinical trials have occurred since the passing of a law 20 years ago, those improvements have begun to level off, according to an expert.

After being a 20-year brain tumor survivor, I met with a genetic counselor and learned that I have a MUYTH gene mutation.

I was feeling fatigued after undergoing breast cancer treatment, but once I started walking multiple times a week, I noticed that I felt much better.

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

A new treatment group within the PYNNACLE clinical trial is set to evaluate a novel drug plus Keytruda in patients with p53 Y220C-mutant locally advanced or metastatic solid tumors.

With society entrenched in an “infodemic,” it can be challenging for many patients with cancer to identify what information online is accurate. Recently, the development of a new tool may help patients decipher what news is misleading.

Drawing helped me stay grounded while my wife was going through cancer treatment.

More than half of patients with metastatic, cisplatin-ineligible bladder cancer saw their cancer shrink when given Padcev and Keytruda in a clinical trial.

Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer.

Watch Dr. Erminia Massarelli, from City of Hope, discuss advancements in early-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

My oncology team and I decided that it was OK to decrease the frequency of cancer-related scans, leaving me both relieved and nervous.

The findings support future studies of assessing the safety and efficacy of the novel drug-chemotherapy combination as a maintenance strategy following stem cell transplantation across a range of blood cancers, according to the study authors.

It baffles me that people take advantage of patients with cancer by peddling fake cures.

Hormone-replacement therapy did not increase chances of death in patients with breast cancer, but certain patient groups may have a higher chance of recurrence from the treatment.

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

An ongoing clinical trial aims to determine if pre- and post-surgical chemotherapy can improve outcomes for patients with stage 2 and 3 gallbladder cancer.

The use of oral paclitaxel and encequidar induced superior outcomes in a group of patients with metastatic breast cancer, compared with paclitaxel delivered intravenously.

Surviving cancer made me thankful for each day. After all, the human lifespan is limited.

If approved, Enhertu may “redefine how we classify and treat metastatic breast cancer,” according to a representative from the drug’s manufacturer.

Watch Nikki Martin, Dr. Ying-Chun Lo and Dr. Hossein Borghaei discuss overcoming barriers to receiving biomarker testing during the CURE Educated Patient Lung Cancer Summit.

Watch Elisabeth King, Dr. Edward S. Kim and Terri Conneran answer questions about targeted therapy during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Edward S. Kim, from City of Hope, discuss targeted therapy during the CURE Educated Patient Lung Cancer Summit.

A cancer caregiver recommends that other caregivers become well-versed in their loved one’s disease.

This year, I returned to the American Society of Clinical Oncology meeting, where I heard about the latest advancements in cancer care, as well as met with fellow patients and advocates.

From Dick Vitale receiving the Jimmy V Award at the 2022 ESPYs to a former triathlon champion opening up about his cancer experience, here’s what’s happening in the cancer space this week.

Watch Elisabeth King, from City of Hope, discuss biomarker testing during the CURE Educated Patient Lung Cancer Summit.

Treatment with FOLFIRINOX, a combination of several chemotherapy agents, prior to the surgical resection of pancreatic cancer increased survival outcomes when compared to historical data.

Investigators are analyzing the novel drug, OP-1250, both as a single-agent treatment option and in combination with Ibrance in patients with recurrent, locally advanced or metastatic ER-positive/HER2-negative breast cancer.

After experiencing complications from breast reconstruction, I’ve decided to go “fabulously flat” and evict my implants.